Ardsley Advisory Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ardsley Advisory Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,000	Closed	-$292K	–	154
2018 Q4	$292K	Buy	+3,000	New	+$394K	0.07%	85
2018 Q3	–	Sell	-5,000	Closed	-$698K	–	192
2018 Q2	$698K	Sell	5,000 -2,000	-29%	-$284K	0.11%	90
2018 Q1	$789K	Sell	7,000 -1,000	-13%	-$126K	0.12%	77
2017 Q4	$1.06M	Buy	+8,000	New	+$940K	0.13%	74
2017 Q2	–	Sell	-4,001	Closed	-$484K	–	195
2017 Q1	$484K	Buy	+4,001	New	+$491K	0.08%	101

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ardsley Advisory Partners's GWPH Position: Q1 2019 in Review

Ardsley Advisory Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 3,000 shares — an estimated $292K sold.

Ardsley Advisory Partners first reported a position in GWPH in Q1 2017 and held it in 5 quarters. The position peaked at $1.06M in Q4 2017. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

Ardsley Advisory Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Ardsley Advisory Partners sold 3,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $292K.
Ardsley Advisory Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 5 quarters.
Ardsley Advisory Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.06M in Q4 2017.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Ardsley Advisory Partners's 13F filing for Q1 2019, filed 15 May 2019.